Work begins on new home for UCL Neuroscience

Ground Breaking Header 825X450 2

This article first appeared in issue 8 of Portico magazine, published November 2021.

In May 2021, UCL President & Provost Dr Michael Spence was joined by construction partner ISG and University College London Hospitals NHS Foundation Trust to break ground at the new centre for UCL Neuroscience. The landmark facility at 256 Grays Inn Road, London, will bring together research scientists, clinicians and patients to create a world-class research and treatment environment to tackle neurological conditions such as dementia, which now count as the world’s leading cause of disability.

The state-of-the-art facilities will house three bodies: the world-leading UCL Queen Square Institute of Neurology; the headquarters of the UK Dementia Research Institute, which is the single biggest investment the UK has ever made in dementia; and the UCLH National Hospital for Neurology and Neurosurgery (NHNN), which is the UK’s largest dedicated neurological and neurosurgical hospital. Co-locating practice with research will support the development of cutting-edge treatment geared towards patients’ needs, enabling advances in clinical practice to happen with little delay.

 

This article first appeared in issue 8 of Portico magazine, published November 2021.

In May 2021, UCL President & Provost Dr Michael Spence was joined by construction partner ISG and University College London Hospitals NHS Foundation Trust to break ground at the new centre for UCL Neuroscience. The landmark facility at 256 Grays Inn Road, London, will bring together research scientists, clinicians and patients to create a world-class research and treatment environment to tackle neurological conditions such as dementia, which now count as the world’s leading cause of disability.

The state-of-the-art facilities will house three bodies: the world-leading UCL Queen Square Institute of Neurology; the headquarters of the UK Dementia Research Institute, which is the single biggest investment the UK has ever made in dementia; and the UCLH National Hospital for Neurology and Neurosurgery (NHNN), which is the UK’s largest dedicated neurological and neurosurgical hospital. Co-locating practice with research will support the development of cutting-edge treatment geared towards patients’ needs, enabling advances in clinical practice to happen with little delay.

 

This article first appeared in issue 8 of Portico magazine, published November 2021.

In May 2021, UCL President & Provost Dr Michael Spence was joined by construction partner ISG and University College London Hospitals NHS Foundation Trust to break ground at the new centre for UCL Neuroscience. The landmark facility at 256 Grays Inn Road, London, will bring together research scientists, clinicians and patients to create a world-class research and treatment environment to tackle neurological conditions such as dementia, which now count as the world’s leading cause of disability.

The state-of-the-art facilities will house three bodies: the world-leading UCL Queen Square Institute of Neurology; the headquarters of the UK Dementia Research Institute, which is the single biggest investment the UK has ever made in dementia; and the UCLH National Hospital for Neurology and Neurosurgery (NHNN), which is the UK’s largest dedicated neurological and neurosurgical hospital. Co-locating practice with research will support the development of cutting-edge treatment geared towards patients’ needs, enabling advances in clinical practice to happen with little delay.